Cargando…

Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report

BACKGROUND: Squamous cell carcinoma of head and neck (SCCHN) is the fifth most common cancer worldwide. Inhibition of epidermal growth factor receptor signaling has been shown to be a critical component of therapeutic option. Herein, we report a case of durable complete response to erlotinib. CASE S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thinn, Mie Mie, Hsueh, Chung-Tzu, Hsueh, Chung-Tsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406195/ https://www.ncbi.nlm.nih.gov/pubmed/30863760 http://dx.doi.org/10.12998/wjcc.v7.i5.616

Ejemplares similares

Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
por: Pan, Jen-Jung, et al.
Publicado: (2010)

Targeted therapy in head/neck and gastric cancers
por: Hsueh, Chung-Tsen
Publicado: (2012)

Metastatic squamous cell carcinoma of colon from esophageal cancer
por: Garg, Natasha, et al.
Publicado: (2017)

Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
por: Stanam, Aditya, et al.
Publicado: (2016)

Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report
por: Wang, Jun, et al.
Publicado: (2010)

Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma
por: Setúbal Destro Rodrigues, Maria Fernanda, et al.
Publicado: (2018)

Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma
por: Jeong, Il Seok Daniel, et al.
Publicado: (2020)

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy
por: Liu, Shuli, et al.
Publicado: (2020)

Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases
por: Read, William L., et al.
Publicado: (2015)

Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma
por: Ngan, Hoi-Lam, et al.
Publicado: (2020)

The role of bile acids in cellular invasiveness of gastric cancer
por: Wu, Yu-Chung, et al.
Publicado: (2018)

2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells
por: Sobhakumari, Arya, et al.
Publicado: (2016)

MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma
por: Jain, Ankit P., et al.
Publicado: (2019)

Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
por: Shaheen, Shagufta, et al.
Publicado: (2018)

Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas
por: William, William N., et al.
Publicado: (2018)

Roles of microRNAs in Regulating Cancer Stemness in Head and Neck Cancers
por: Fitriana, Melysa, et al.
Publicado: (2021)

Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
por: Shen, Yujie, et al.
Publicado: (2022)

Head and Neck Cylindroma Masquerading as Squamous Cell Carcinoma: A Case Report
por: Konkimalla, Abhilash, et al.
Publicado: (2020)

MAPK1(E322K) mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin
por: Wen, Yihui, et al.
Publicado: (2016)

Near complete response to a pembrolizumab-based therapeutic strategy in an abdominal metastatic head and neck squamous cell carcinoma case
por: Wu, Taowei, et al.
Publicado: (2022)

Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab
por: Tsai, Hsin Hsiang Clarence, et al.
Publicado: (2021)

Survival Outcomes of Complete Pulmonary Metastasectomy for Head and Neck Squamous Cell Carcinomas
por: Kuroda, Hiroaki, et al.
Publicado: (2022)

A Fatal Case of Primary Basaloid Squamous Cell Carcinoma in the Intrahepatic Bile Ducts
por: Kirkegaard, Johan, et al.
Publicado: (2014)

Confluent tracheal recurrences of head and neck squamous cell carcinoma
por: Bleiberg, Benjamin Aaron, et al.
Publicado: (2019)

The prognostic importance of parotid involvement by head and neck squamous cell carcinoma - Case report
por: Gouveia, Bruna Melhoranse, et al.
Publicado: (2016)

Thyroid dysfunction from inhibitor of fibroblast growth factor receptor
por: Ahn, Jeffrey, et al.
Publicado: (2019)

A Case Report of Nongerminal Center B-Cell Type Diffuse Large B-Cell Lymphoma Treated to Complete Response with Rituximab and Ibrutinib
por: Shouse, Geoffrey, et al.
Publicado: (2018)

Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature
por: Acharya, Utkarsh, et al.
Publicado: (2008)

Updates in Gastrointestinal Oncology – insights from the 2008 44(th )annual meeting of the American Society of Clinical Oncology
por: Javle, Milind, et al.
Publicado: (2009)

Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology
por: Javle, Milind, et al.
Publicado: (2010)

Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
por: Li, Rui, et al.
Publicado: (2013)

Long Term Survivor with Erlotinib in Metastatic Lung Cancer-Squamous Cell Carcinoma Subtype
por: VATU, BOGDAN IONEL, et al.
Publicado: (2020)

Promoter Methylation in Head and Neck Squamous Cell Carcinoma Cell Lines Is Significantly Different than Methylation in Primary Tumors and Xenografts
por: Hennessey, Patrick T., et al.
Publicado: (2011)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Pancytopenia associated with clonazepam
por: Bautista-Quach, Marnelli A, et al.
Publicado: (2010)

Anthracycline-induced cardiotoxicity: A case report and review of literature
por: Chong, Esther G, et al.
Publicado: (2021)

A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer
por: Sanghvi, Samrat M., et al.
Publicado: (2022)

Pseudoprogression in the era of immunotherapy-based strategies for recurrent head and neck squamous cell carcinoma achieving complete response: A case report
por: Zhou, Jiawei, et al.
Publicado: (2023)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_r6m6jj2nnctolfbmfac01minbk